Eli Lilly and Co. stock trades at EUR 1,056.60, 4.6 percent below its 52-week high

Published on 10/12/2026 at 16:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eli Lilly and Co. stock costs EUR 1,056.60 on October 12, 2026, EUR 50.40 below its 52-week high. The high is EUR 1,107.00.

Key points in brief

Eli Lilly and Co. stock was at EUR 1,056.60 at Lang & Schwarz on October 12, 2026.
The price was 4.55 percent below the EUR 1,107.00 52-week high.
Market capitalization stood at USD 994.5 billion, with a P/E ratio of 39.64.

Architekturaufnahme eines modernen Glas-Stahl-Technologiecampus in Fremont, Kalifornien, bei warmem Goldstundenlicht — Lam Research US5324571083 moderner Hightech Campus Fremont Kalifornien Glas Stahl Goldstundenlicht Architektur, Illustration mit AI erstellt.

Eli Lilly and Co. stock (ISIN US5324571083) was trading at EUR 1,056.60 at Lang & Schwarz on October 12, 2026 at 4:36 p.m. CEST, up 1.13 percent versus the Xetra close of October 9, 2026 at EUR 1,044.80. The price remains EUR 50.40 below the 52-week high of EUR 1,107.00, giving the session a clear range context.

Intraday price stays near high

The Lang & Schwarz bid was EUR 1,056.00 and the ask was EUR 1,057.20 at 4:36 p.m. CEST. The current price is 4.55 percent below the 52-week high of EUR 1,107.00 and EUR 393.70 above the 52-week low of EUR 662.90.

Valuation carries the market story

Eli Lilly and Co. had a market capitalization of USD 994.5 billion as of October 12, 2026. Its P/E ratio was 39.64 and its dividend yield was 0.01 percent, placing valuation and earnings expectations alongside the stock's position near the upper end of its annual range.

The US listing is on the Nasdaq under ticker LLY, according to Global Banking and Finance. The same market profile identifies Eli Lilly and Co. with ISIN US5324571083 and places the company in the health care sector.

Comparison with peers

Eli Lilly and Co.: plus 1.13 percent, P/E 39.64, market capitalization USD 994.5 billion

Pfizer (NYSE, USD): plus 0.19 percent, P/E 37.44, market capitalization USD 161.5 billion

Novo Nordisk (Nasdaq Copenhagen, DKK): , ,

Results date is October 29

Eli Lilly and Co. is scheduled to hold its third-quarter 2026 earnings call on October 29, 2026 at 10:00 a.m. EDT, according to Eli Lilly and Co. The date gives the market a defined calendar point for the next reported operating figures.

Stock remains below its yearly high

At EUR 1,056.60, Eli Lilly and Co. stock stood 4.55 percent below its 52-week high and 59.41 percent above its 52-week low on October 12, 2026. The session price was 1.13 percent above the October 9 Xetra close of EUR 1,044.80.

The further course of trading is shown by the continuously updated real-time quote of Eli Lilly and Co stock.